Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Baxter
Merck
Healthtrust
Fuji
Colorcon
Teva
Moodys
Julphar

Generated: November 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020145

« Back to Dashboard

NDA 020145 describes NITRO-DUR, which is a drug marketed by Uspharma and is included in one NDA. It is available from one supplier. Additional details are available on the NITRO-DUR profile page.

The generic ingredient in NITRO-DUR is nitroglycerin. There are thirty-six drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
Summary for 020145
Tradename:NITRO-DUR
Applicant:Uspharma
Ingredient:nitroglycerin
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020145
Ingredient-typeNitrates
Physiological EffectVasodilation
Medical Subject Heading (MeSH) Categories for 020145
Suppliers and Packaging for NDA: 020145
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NITRO-DUR nitroglycerin FILM, EXTENDED RELEASE;TRANSDERMAL 020145 NDA Ingenus Pharmaceuticals, LLC 50742-513 50742-513-30 30 POUCH in 1 BOX, UNIT-DOSE (50742-513-30) > 1 PATCH in 1 POUCH
NITRO-DUR nitroglycerin FILM, EXTENDED RELEASE;TRANSDERMAL 020145 NDA Ingenus Pharmaceuticals, LLC 50742-514 50742-514-30 30 POUCH in 1 BOX, UNIT-DOSE (50742-514-30) > 1 PATCH in 1 POUCH

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength0.1MG/HR
Approval Date:Apr 4, 1995TE:AB1RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength0.2MG/HR
Approval Date:Apr 4, 1995TE:AB1RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength0.3MG/HR
Approval Date:Apr 4, 1995TE:RLD:Yes

Expired US Patents for NDA 020145

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Uspharma NITRO-DUR nitroglycerin FILM, EXTENDED RELEASE;TRANSDERMAL 020145-001 Apr 4, 1995 ➤ Sign Up ➤ Sign Up
Uspharma NITRO-DUR nitroglycerin FILM, EXTENDED RELEASE;TRANSDERMAL 020145-004 Apr 4, 1995 ➤ Sign Up ➤ Sign Up
Uspharma NITRO-DUR nitroglycerin FILM, EXTENDED RELEASE;TRANSDERMAL 020145-006 Apr 4, 1995 ➤ Sign Up ➤ Sign Up
Uspharma NITRO-DUR nitroglycerin FILM, EXTENDED RELEASE;TRANSDERMAL 020145-003 Apr 4, 1995 ➤ Sign Up ➤ Sign Up
Uspharma NITRO-DUR nitroglycerin FILM, EXTENDED RELEASE;TRANSDERMAL 020145-002 Apr 4, 1995 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Fish and Richardson
Harvard Business School
Baxter
Deloitte
Fuji
Healthtrust
Farmers Insurance
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.